Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Humacyte Inc., 3 years.
Humacyte Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Humacyte Inc. June 11, 202499.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 18, 2026 | Humacyte Inc. | Open-market purchase | +11,000 | $0.89 | $9,790 |
| Apr 7, 2025 | Humacyte Inc. | Open-market purchase | +16,000 | $1.26 | $20,160 |
| Dec 4, 2024 | Humacyte Inc. | Open-market purchase | +4,600 | $4.39 | $20,194 |
| Aug 15, 2024 | Humacyte Inc. | Open-market purchase | +3,100 | $6.29 | $19,499 |
| May 18, 2023 | Humacyte Inc. | Open-market purchase | +4,750 | $4.18 | $19,855 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.